Skip to main content
OpenTrials

Clinical trial condition

Advanced Urothelial Carcinoma

Explore clinical trials studying Advanced Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

22 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Advanced Urothelial Carcinoma trial results

Recruiting

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

NCT07241793

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +5 more
Locations
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
  • Sun yat-sen university cancer center Guangzhou, Guangdong, China
  • The fifth Affiliated Hospital of Guangzhou Medcial University Guangzhou, Guangdong, China
  • Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

NCT05929235

Conditions
Advanced Urothelial Carcinoma, Open Label, Oral Drug Administration
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View Trial Details
Recruiting

Probiotics in Advanced Urothelial Carcinoma

NCT06904573

Conditions
Advanced Urothelial Carcinoma, Immunotherapy, Probiotics
Locations
  • Sun yat-sen university cancer center Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
View Trial Details

Related conditions